Detalhe da pesquisa
1.
Target product profiles: tests for tuberculosis treatment monitoring and optimization.
Bull World Health Organ
; 101(11): 730-737, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37961060
2.
Tuberculosis incidence in foreign-born people residing in European countries in 2020.
Euro Surveill
; 28(42)2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855907
3.
Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.
PLoS Med
; 19(6): e1004032, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35696431
4.
Analysis of the Clinical Pipeline of Treatments for Drug-Resistant Bacterial Infections: Despite Progress, More Action Is Needed.
Antimicrob Agents Chemother
; 66(3): e0199121, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35007139
5.
Prioritising attributes for tuberculosis preventive treatment regimens: a modelling analysis.
BMC Med
; 20(1): 182, 2022 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35581650
6.
Evidence-based Definition for Extensively Drug-Resistant Tuberculosis.
Am J Respir Crit Care Med
; 204(6): 713-722, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34107231
7.
Antimicrobial Resistance in Africa-How to Relieve the Burden on Family Farmers.
Emerg Infect Dis
; 27(10): 2515-2520, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34545788
8.
Advances in clinical trial design: Weaving tomorrow's TB treatments.
PLoS Med
; 17(2): e1003059, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32106220
9.
Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.
Emerg Infect Dis
; 25(5): 936-943, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31002070
10.
Advances in clinical trial design for development of new TB treatments: A call for innovation.
PLoS Med
; 16(3): e1002769, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30901322
11.
Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance.
PLoS Med
; 16(9): e1002915, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31490921
12.
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape.
PLoS Med
; 16(3): e1002767, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30901331
13.
An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease.
Eur Respir J
; 52(4)2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30139776
14.
Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model.
PLoS Med
; 14(1): e1002202, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28045934
15.
Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis.
Antimicrob Agents Chemother
; 61(7)2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28438924
16.
Reply to Kaye and Belley, "Third-Generation Cephalosporin-Resistant Enterobacterales Are Critical Priority Pathogens, Too!"
Antimicrob Agents Chemother
; 66(4): e0022322, 2022 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323014
17.
A four-month gatifloxacin-containing regimen for treating tuberculosis.
N Engl J Med
; 371(17): 1588-98, 2014 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25337748
18.
World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.
Eur Respir J
; 49(3)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28331043
19.
Driving the Way to Tuberculosis Elimination: The Essential Role of Fundamental Research.
Clin Infect Dis
; 63(3): 370-5, 2016 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27270671
20.
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Clin Infect Dis
; 63(7): 853-67, 2016 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27621353